Status:
UNKNOWN
Prospective Registry of Corona Virus Disease 2019 (Covid-19) Patients With Neuromuscular Involvement
Lead Sponsor:
University Hospital Tuebingen
Conditions:
COVID
Sars-CoV2
Eligibility:
All Genders
18+ years
Brief Summary
Prospective registry for multimodal assessment of neuromuscular pathology associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, enrolling consecutive patients with co...
Detailed Description
The prospective registry shall provide new insights into muscular involvement associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. For that reason consecutive patien...
Eligibility Criteria
Inclusion
- Age ≥ 18 years
- Proven severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection
Exclusion
- active or known history of myopathy or advanced stage neuropathy
- refusal to participate in clinical research
Key Trial Info
Start Date :
March 20 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 31 2022
Estimated Enrollment :
500 Patients enrolled
Trial Details
Trial ID
NCT04367350
Start Date
March 20 2020
End Date
March 31 2022
Last Update
April 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Hospital Tuebingen
Tübingen, Germany, 72076